During the past decade, National Center for Tuberculosis Problems conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Tuberculosis Problems" #1 collaborator was "Epicentre" with 2 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator, "Interactive Research and Development" with 2 trials as a collaborator and "Partners in Health" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "National Center for Tuberculosis Problems" are "Pulmonary Tuberculoses" (2 trials), "Tuberculosis, Multidrug-Resistant" (2 trials), "Bacterial Infections" (1 trials), "Gram-Positive Bacterial Infections" (1 trials) and "Infection, Bacterial" (1 trials). Many other conditions were trialed in "National Center for Tuberculosis Problems" in a lesser frequency.

Most popular intervention types in "National Center for Tuberculosis Problems" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline" (1 trials), "Bedaquiline 100 MG" (1 trials), "Clofazimine" (1 trials), "Clofazimine 100 MG Oral Capsule" (1 trials) and "Control arm MDR-TB regimen, consistent with WHO guidelines" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Center for Tuberculosis Problems" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Center for Tuberculosis Problems". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Center for Tuberculosis Problems, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Center for Tuberculosis Problems, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".